DOCTOR'S VIEW ARCHIVE
Post-Traumatic Stress Disorder - Treatment
The US Food and Drug Administration (FDA) approved sertraline (Zoloft), a drug commonly used to manage depression, as the first medication specifically for the treatment of post-traumatic stress disorder.
Post-traumatic stress disorder is a pattern of behavior that develops after a traumatic event. A traumatic event in this context is defined as one that may bring serious injury or death to oneself or to another person. Traumatic events capable of causing post- traumatic stress disorder include kidnapping, natural disasters (hurricanes, earthquakes, tornadoes, floods, etc), physical and sexual abuse, combat, drug abuse, and near-death experiences.
Historically referred to as "soldier's heart" and "shell shock" because the behavior characteristic of post-traumatic stress disorder was seen in men after wartime combat, the symptoms and behaviors of post-traumatic stress disorder have been shown to occur in children, adolescents, and adults.
Constellation of changes in post-traumatic stress
Persons with post-traumatic stress disorder may continuously experience flashbacks. During these flashbacks they relive the traumatic event and reexperience feelings of intense fear and of inability to escape from the traumatic event. Every effort is taken to avoid actions or thoughts associated with the traumatic event in order to prevent these flashbacks.
Ultimately, behavior becomes erratic and hyperactive, as if the individual were constantly defending himself. For example, the person may develop anxiety, have disturbed sleep, and be easily startled. Over the long run this behavior can lead to complete dysfunction with a sense of hopelessness, a total lack of self- esteem, and overwhelming fear of people. There also may be substance abuse (use of alcohol or narcotics, for example) and difficulty maintaining existing relationships.
Variable duration of the disorder
About 4% of the general population or approximately 10 million people develop post-traumatic stress disorder each year. It is twice as common in women as in men. In one study it was found to occur in 15% of war veterans up to19 years after combat. Several factors including psychological traits, genetics factors and life experiences may contribute to the likelihood of developing post-traumatic stress disorder.
For most patients with post-traumatic stress disorder, treatment has consisted of counseling, psychotherapy, or drugs. A combination of these approaches is sometimes employed. We will focus here on the drugs used for post-traumatic stress disorder.
Drug treatment of post-traumatic stress disorder
New research has revealed how severe trauma can produce long-term changes in the nerves in the brain. In particular, it is now believed that the problem is caused by alterations in the chemical substances that nerves in the brain use to communicate with each other, substances referred to as neurotransmitters. These alterations in neurotransmitters may be responsible for the symptoms and behaviors.
Treatment of post-traumatic stress disorder has therefore shifted to drugs that target these chemical substances. For example, antidepressants including imipramine and phenelzine (Nardil) that alter neurotransmitters such as serotonin, norepinephrine, dopamine, and acetylcholine have been found do more to reduce flashbacks and the feelings of helplessness more than placebo (a dummy pill). Unfortunately, however, side effects interfered with the long-term use of these drugs.